Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non- ST-elevation acute coronary syndrome: The clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial

Circulation

Volumn 110, Issue 10, 2004, Pages 1202-1208

  Fox, Keith A A ^a,f   Mehta, Shamir R ^b   Peters, Ron ^c   Zhao, Feng ^b   Lakkis, Nasser ^d   Gersh, Bernard J ^e   Yusuf, Salim ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Baylor Hospital   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Clopidogrel; Coronary artery bypass; Coronary disease; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO;

ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DOSE RESPONSE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LETHALITY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION; STROKE; SURGICAL PATIENT; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ADULT; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; RISK; TICLOPIDINE; TREATMENT OUTCOME;

EID: 4444229924     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000140675.85342.1B     Document Type: Article

References (19)

1. Collaborative meta-analysis of randomized trials of anti-platelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients: Anti-Platelet Trialists' Collaboration. BMJ. 2002;324:71-86.
2. Kong DF, Califf RM, Miller DP, et al. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation. 1998;98:2829-2835.
3. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002;359:189-198.
4. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
5. Mehta S, Yusuf S, Peters RJG, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
6. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436-443.
7. PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 1998;338:1498-1505.
8. GUSTO-IV ACS Investigators. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomised trial. Lancet. 2001;357:1915-1924.
9. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study: Fragmin and Fast Revascularization During Instability in Coronary Artery Disease (FRISC II) Investigators. Lancet. 1999;354:708-715.
10. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial: FRISC II Investigators: Fast Revascularisation During Instability in Coronary Artery Disease. Lancet. 2000;356:9-16.
11. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
12. Berkowitz SD, Granger CB, Pieper KS, et al, for the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) I Investigators. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. Circulation. 1997;95:2508-2516.
13. Fox KAA, Poole-Wilson PA, Henderson RA, et al, for the Randomized Intervention Trial of Unstable Angina (RITA) Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 2002;360:743-751.
14. MacMahon S, Collins R, Peto R, et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomised, controlled trials. JAMA. 1988;260:1910-1916.
15. Fox KAA, Goodman SG, Klein W, et al, for the GRACE Investigators. Management of acute coronary syndromes: variations in practice and outcome: findings of the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002;23:1177-1189.
16. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of acute coronary syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190-1201.
17. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309-1317.
18. Steinhubl SR, Berger PB, Mann JT 3rd, et al, for the CREDO Investigators. Clopidogrel for the Reduction of Events During Observation: early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomised controlled trial. JAMA. 2002;288:2411-2420.
19. Kongo RH, Ley J, Dick SE, et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol. 2002;40:231-237.